<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0409234124
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2005
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DEXTROSE 70% SOLUTION  
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DEXTROSE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        70
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        6
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        435.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAXTER CORPORATION" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAXTER CORPORATION
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 416]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Arabian Health Care Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAXTER CORPORATION
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        V06DC01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Throughout this leaflet, Dextrose 70% w/v Concentrate for Solution for Infusion will be called Glucose Concentrate.</strong></p><p>Glucose Concentrate is a sterile solution of concentrated glucose. The glucose is used to provide energy and to increase the amount of sugar in your blood.</p><p>Glucose Concentrate is used if:</p><ul><li>you are unable to take enough food by mouth. It is mixed with other nutrition solutions that will be given to you by infusion through your vein.</li><li>you have increased fluid pressure in your skull and are unconscious due to having low blood sugar. It will provide relief from the symptoms.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not receive Glucose Concentrate if you are suffering from any of the following conditions: </strong></p><ul><li>a significantly higher level of sugar in your blood than normal (hyperglycaemia).</li><li>sensitivity (hypersensitivity) to glucose. The glucose in this product is derived from corn.</li></ul><p><strong>Warnings and Precautions</strong></p><p>Please tell your doctor if you have, or have had, any of the following medical conditions:</p><ul><li>diabetes.</li><li>kidney disease.</li><li>an acute critical illness that has started recently and could be life-threatening.</li><li>high pressure within the skull (intracranial hypertension).</li><li>if you have had a head injury in the past 24 hours.</li><li>a stroke due to a clot in a blood vessel in the brain (ischaemic stroke).</li><li>heart disease (heart failure).</li><li>lung disease (respiratory failure).</li><li>reduced production of urine (oliguiria or anuria).</li><li>excess water in the body (water intoxication).</li><li>low level of sodium in the blood (hyponatraemia).</li><li>allergy to corn (Glucose Concentrate contains sugar derived from corn).</li><li>precipitates. Because of the potential for life-threatening events, caution should be taken to ensure that precipitates have not formed in any parenteral nutrient admixture.</li><li>liver disorders. There have been reports of liver problems and liver failure in patients who take intravenous nutrition therapy. If you suffer symptoms such as nausea, vomiting, abdominal pain, yellowing of the skin or eyes, contact your doctor immediately.</li><li>catheter infection/sepsis. Certain medications and illnesses can increase the risk of developing infection or sepsis (bacteria in the blood). There is a particular risk of infection or sepsis when a tube (intravenous catheter) is placed in your vein. Your doctor will carefully watch you for any signs of infection. Patients who require parenteral nutrition (giving nutrition through a tube in your vein) may be more likely to develop infections from their medical conditions. Using aseptic (&ldquo;germ-free&rdquo;) techniques when placing and caring for the catheter and when making the nutritional formula (TPN) can reduce the risk of infection.</li><li>If you have a condition that could cause high levels of vasopressin, a hormone regulating fluid in your body. You may have too much vasopressin in your body because, for example:<ul><li>you have had a sudden and serious illness,</li><li>you are in pain,</li><li>you have had surgery,</li><li>you have infections, burns, brain disease</li><li>diseases linked to your heart, liver, kidneys or central nervous system,</li><li>because you are taking certain medicines (see also below &ldquo;Other medicines and Glucose solutions&rdquo;).</li></ul></li></ul><p>This may increase the risk of low level of sodium in your blood and can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain and death. Brain swelling increases the risk of death and brain damage. People who are at higher risk of brain swelling are:</p><ul><li>young people</li><li>women (particularly if you are of a fertile age)</li><li>people who have problems with their brain fluid levels, for example, because of meningitis, bleeding in the skull or a brain injury.</li></ul><p>If you are not sure if any of the above apply to you, talk to your doctor or nurse before having Glucose Concentrate.</p><p>When you are given Glucose Concentrate, your doctor will monitor:</p><ul><li>the amount of electrolytes such as sodium and potassium in your blood (your plasma electrolytes).</li><li>the amount of sugar (glucose).</li><li>the amount of fluid in your body (your fluid balance).</li><li>the acidity of your blood and urine (changes in acid-base balance).</li></ul><p>Your doctor will adjust how much Glucose Concentrate you are given according to the results of these tests. These tests will also tell your doctor if you need extra potassium, an electrolyte (salt) in your blood. If required, this can be given into a vein.</p><p>As Glucose Concentrate contains sugar (glucose), it can cause a high level of sugar in your blood (hyperglycaemia). If this occurs, your doctor may:</p><ul><li>adjust the speed of infusion.</li><li>give insulin to reduce the amount of sugar in your blood.</li><li>if necessary, give you extra potassium.</li></ul><p>This is particularly important:</p><ul><li>if you are diabetic.</li><li>if your kidneys do not work as well as normal.</li><li>if you have recently had a stroke (acute ischaemic stroke). High levels of sugar in the blood can worsen the effects of stroke and affect recovery.</li><li>if you have metabolic disturbances due to starvation or due to a diet which does not provide the right proportion of the necessary nutrients (malnutrition).</li><li>you have a low level of thiamine (vitamin B1). This can happen if you suffer from chronic alcoholism.</li></ul><p><strong>Children</strong></p><p>Glucose Concentrate should be given with special care in children.</p><p>Children must be given Glucose Concentrate by a doctor or nurse. The amount given must be decided by a doctor specialising in the care of children and will depend upon the child&rsquo;s age, weight, and condition. If the Glucose Concentrate is used to deliver or dilute another medicine, or if other medicines are given at the same time, this may affect the dose.</p><p>When the Glucose Concentrate is given to children, the child&rsquo;s dotor will take blood and urine samples to monitor the amount of electrolytes such as potassium in the blood (plasma electrolytes).</p><p>Newborns &ndash; especially those born premature and with low birth weight &ndash; are at increased risk of developing a too low or too high level of sugar in the blood (hypo- or hyperglycaemia) and therefore need close monitoring during treatment with intravenous glucose solutions to ensure adequate control of the sugar levels in order to avoid potential long term adverse effects. Low sugar levels in the newborn can cause prolonged seizures, coma and brain damage. High sugar levels have been associated with bleeding into the brain, bacterial and fungal infection, damage to the eye (retinopathy of prematurity), infections in the intestinal track (necrotizing enterocolitits), lung problems (bronchopulmonary dysplasia), prolonged length of hospital stay and death.</p><p>When administered to a newborn baby, the solution bag could be connected to an infusion pump device, which allows exact delivery of the required quantity of solution across the defined time interval. Your doctor or nurse will be monitoring the device to ensure safe administration.</p><p>Children (including neonates and older children) who are given Glucose Concentrate are at a higher risk of developing a low sodium level in the blood (hypoosmotic hyponatraemia) and a disorder affecting the brain due to low levels of sodium (hyponatraemic encephalopathy).</p><p><strong>Other medicines and Glucose Concentrate </strong></p><p>Tell your doctor or nurse if you are using, have recently used or might use other medicines. Glucose Concentrate and other medicines taken at the same time can affect each other.</p><p>Some medicines act on the hormone vasopressin. These may include:</p><ul><li>anti-diabetic medication (chlorpropamide)</li><li>cholesterol medicine (clofibrate)</li><li>some cancer drugs (vincristine, ifosfamide, cyclophosphamide)</li><li>selective serotonin reuptake inhibitors (used to treat depression)</li><li>antipsychotics or opioids for severe pain relief</li><li>medicines for pain and/or inflammation (also known as NSAIDs)</li><li>medicines that imitate or strengthen the effects of vasopressin such as desmopressin (used to treat increased thirst and urination), terlipressin (used to treat bleeding of the gullet) and oxytocin (used to induce labour)</li><li>anti-epileptic medication (carbamazepine and oxcarbazepine)</li><li>diuretics (water tablets).</li></ul><p><strong>Having blood transfusions while you are having Glucose Concentrate </strong></p><p>Whilst you are having Glucose Concentrate you will not be given a blood transfusion through the same tubing as the Glucose Concentrate. Also, blood will not be given before or after using the same infusion tube, as this may make the blood clot.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.</p><p><strong><em>Pregnancy</em></strong></p><p>Glucose Concentrate can be used during pregnancy. However, caution should be taken when glucose Concentrate is used during child birth.</p><p><strong><em>Fertility </em></strong></p><p>There are no adequate data of the effect of Glucose on fertility.</p><p><strong><em>Lactation </em></strong></p><p>There are no adequate data of the effect of Glucose Concentrate during breast-feeding. Glucose solutions have been used during breast-feeding.</p><p><strong>Driving and using machines</strong></p><p>There is no information on the effects of intravenous glucose on the ability to operate a vehicle or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Glucose Concentrate will be given to you by a doctor or nurse.</p><p><strong>The usual dose</strong></p><p>Your doctor will decide how much of the medicine you will need and for how long it will be given to you. The dose will depend on:</p><ul><li>your age and weight</li><li>the reason you are being given the medicine</li></ul><p><strong>How Glucose Concentrate is prepared and given</strong></p><ul><li>Glucose Concentrate will be diluted with other nutrition solutions before it is given to you.</li><li>The dilution will be done under sterile conditions by a trained and qualified person.</li><li>The diluted solution will be stored at 2 to 8&deg;C and used within 24 hours of mixing.</li></ul><p>It will be given to you via a plastic tube, which will be placed very carefully into your vein, usually in your chest.</p><p>Your doctor will check that any medicines added to your infusion are compatible with Glucose Concentrate.</p><p>Before and during the infusion, your doctor will monitor:</p><ul><li>the amount of fluid in your body</li><li>the acidity of your blood and urine</li><li>the amount of electrolytes in your body (particularly sodium, in patients with high levels of the hormone vasopressin, or are taking other medicines which increase the effects of vasopressin).</li></ul><p><strong>If you are given more Glucose Concentrate than you should have</strong></p><p>If you are given too much Glucose Concentrate (over-infusion) or it is given too fast, or too often, this may lead to the following symptoms:</p><ul><li>build-up of liquid in the tissues causing swelling (oedema) or water intoxication with lower level than normal of sodium in the blood (hyponatraemia)</li><li>a higher amount of sugar in the blood than normal (hyperglycaemia)</li><li>the blood becomes too concentrated (hyperosmolarity)</li><li>sugar in the urine (hyperglycosuria)</li><li>an increase in the amount of urine you produce (osmotic diuresis)</li><li>a loss of water from the body (dehydration)</li></ul><p>If you develop any of these symptoms, you must inform your doctor immediately. Your infusion will be stopped or reduced. Insulin should be administered and you will be given treatment depending on your symptoms.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Side effects can include:</p><ul><li>hypersensitivity reactions, including a serious allergic reaction called anaphylaxis (potential manifestation in patients with allergy to corn).</li><li>changes in the levels of the electrolytes in the blood (electrolyte disturbances), including:<ul><li>low levels of sodium in the blood that may be acquired during hospitalization (nosocomial hyponatraemia) and related neurological disorder (acute hyponatraemic encephalopathy). Hyponatraemia can lead to irreversible brain injury and death due to cerebral oedema swelling (see also in the section &ldquo;Warning and precautions&rdquo;)</li></ul></li><li>a high level of sugar in the blood (hyperglycaemia).</li><li>an excess of fluid in the blood vessels (haemodilution and hypervolaemia).</li><li>sugar in your urine (glycosuria).</li><li>reactions related to the route of administration:<ul><li>fever, febrile reaction (pyrexia).</li><li>infection at the site of injection.</li><li>escape of the Glucose Concentrate into the tissues around the vein (extravasation). This can damage the tissues and cause scarring.</li><li>the formation of a blood clot (venous thrombosis) at the site of infusion, which causes pain, swelling and redness in the area of the clot.</li><li>irritation and inflammation of the vein into which the solution was infused (phlebitis). This can cause redness, pain or burning and swelling along the path of the vein into which the solution is infused.</li><li>local pain or reaction (redness or swelling at the site of infusion).</li></ul></li><li>shivering.</li><li>sweating.</li><li>formation of small particles blocking lung blood vessels.</li></ul><p>If any side effects occur, the infusion must be stopped.</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.</p><ul><li><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:661px"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><ul><li><strong>Other GCC States:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:661px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Hospital staff will ensure that the product is stored and disposed of correctly and not used after the expiry date stated on the product. The storage conditions should you need them are given below.</p><ul><li>Do not store above 25&deg;C.</li><li>Do not freeze.</li><li>Store in original packaging.</li><li>Do not use Glucose Concentrate after the expiry date that is stated on the label. The expiry date refers to the last date of that month.</li><li>Glucose Concentrate must not be used if the solution is not clear or the bag is damaged.</li></ul><p>Each bag will be used once. Any left-over concentrate will be discarded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This leaflet does not contain all the information about for this medicine. If you have any questions or are not sure about anything, ask your healthcare professional.</p><p><strong>What Glucose Concentrate contains</strong></p><ul><li>The active substance is Glucose Monohydrate 77% w/v (770 g per 1000 ml), which is equivalent to Anhydrous Glucose 70% w/v (700 g per 1000 ml).</li><li>The other ingredient is sterile water (called &lsquo;water for Injections&rsquo;).</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Glucose Concentrate is as a clear, slightly yellow solution. It is available in flexible plastic bags, which contain 2000 ml of concentrate. 
The bags are supplied in cartons. Each carton contains 6 bags of 2000 mL

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>MARKETING AUTHORISATION HOLDER</strong></p><p><strong>Baxter Healthcare Corporation</strong></p><p>60015 Deerfield, IL, USA</p><p><strong>MANUFACTURER</strong></p><p><strong>Baxter Healthcare Corporation</strong></p><p>65 Pitts Station Rd , 28752 Marion, NC, USA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in October 2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>خلال هذه النشرة، سيعرف دكستروز </strong><strong>70% w/v &rlm;</strong>‫<strong>مُرَّكز لمحلول التسريب اختصارًا باسم مُرَّكز الجلوكوز.</strong></p><p dir="RTL">مُرَّكز الجلوكوز هو محلول معقم من الجلوكوز المركز. يُستخدَم الجلوكوز ليوفر الطاقة للجسم ويزيد من كمية السكر في الدم.</p><p dir="RTL">يُستخَدم مُرَّكز الجلوكوز في الحالات التالية:</p><ul dir="rtl"><li>عندما لا يكون بمقدورك تناول طعام كاف عن طريق الفم. يتم خلطه بمحاليل تغذية أخرى ويتم إعطاؤه لك عن طريق التسريب عبر الوريد.</li><li>إذا زاد ضغط السوائل في الجمجمة وفقدت الوعي بسبب انخفاض السكر في الدم. سيوفر الراحة من الأعراض.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عليك عدم الحصول على مُرَّكز الجلوكوز إذا كنت تعاني من أي من الحالات التالية: </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستوى السكر في الدم عن المعدل الطبيعي بدرجة كبيرة (ارتفاع السكر في الدم).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية (فرط تحسس) ضدّ الجلوكوز. الجلوكوز في هذا المنتج مشتق من الذرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يُرجى إخبار الطبيب أو الصيدلي بما إذا كنت تعاني أو قد عانيت من الحالات الطبية التالية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السكري.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض الكلى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض عضال حاد وهو مرض ظهر حديثاً ويمكن أن يشكّل خطراً على الحياة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع الضغط داخل الجمجمة (فرط الضغط داخل القحف).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرّضت لإصابة في الرأس خلال الـ 24 ساعة الماضية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سكتة دماغية بسبب جلطة في وعاء دموي في الدماغ (سكتة دماغية إقفارية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض القلب (فشل قلبي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض الرِّئَة (فشل في التنفس).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قِلّة البَول أو انقطاع البول.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية مياه زائدة في الجسم (التسمّم المائي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يكون مستوى الصوديوم في الدم منخفضاً (نقص الصوديوم في الدم).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية من الذرة (يحتوي مُرَّكز الجلوكوز على سكر مشتقّ من الذرة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرواسب. نظرًا لاحتمالية وقوع حالات مهددة للحياة، يجب توخي الحذر للتأكد من عدم تكون الرواسب في أي مخلوط للتغذية بالحقن.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الكبد. تم الإبلاغ عن مشاكل في الكبد والفَشَل الكَبِدَيّ لدى المرضى الذين يتناولون العلاج بالتغذية الوريدية. &rlm;‫إذا كنت تعاني من أعراض مثل الغثيان والتَقَيُّء والألم البطني واصفرار الجلد أو العينين، فاستشر طبيبك على الفور.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى في القِثْطار/إنتان. يمكن لبعض الأدوية والأمراض أن تزيد من خطر الإصابة بالعدوى أو إنتان (بكتريا في الدم). تزيد خطورة الإصابة بالعدوى أو الإنتان في حالة وضع أنبوب في الوريد (القسطرة الوريدية). ستخضع للملاحظة الدقيقة من طبيبك للتأكد من عدم وجود عدوى. قد يكون المرضى الذين يحتاجون إلى التغذية بالحقن (الحصول على التغذية بواسطة أنبوب يتم وضعه في الوريد) أكثر عرضة للإصابة بعدوى من حالاتهم الطبية. إن استخدام تقنيات معقمة (&quot;خالية من الجراثيم&quot;) عند وضع القسطرة والعناية بها وعند إعطاء التغذية الكاملة بالحقن من شأنه أن يقلل من مخاطر العدوى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك حالة يمكن أن تسبب مستويات عالية من هرمون فازوبريسين، وهو هرمون ينظم السوائل في جسمك. قد يكون لديك الكثير من فازوبريسين في جسمك، على سبيل المثال:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أصبت بمرض مفاجئ وخطير،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشعر بالألم،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خضعت لجراحة،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك عدوى أو حروق أو مرض في المخ</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك أمراض مرتبطة بالقلب أو الكبد أو الكلى أو الجهاز العصبي المركزي،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لأنك تتناول أدوية معينة (راجع أيضًا أدناه &quot;الأدوية الأخرى ومحاليل الجلوكوز&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يزيد ذلك من خطر انخفاض مستوى الصوديوم في الدم، ما قد يؤدي إلى الصداع والغثيان والنوبات والنوام والغيبوبة وتَوَرُّم الدماغ والوفاة. يزيد تَوَرُّم الدماغ من الوفاة وتلف الدماغ. الأشخاص الأكثر عرضة لتَوَرُّم الدماغ هم:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصغار</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النساء (خاصةً إذا كنت في سن الإنجاب)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأشخاص الذين يعانون من مشاكل في مستويات سوائل الدماغ، على سبيل المثال، بسبب التهاب السحايا أو نزيف في الجمجمة أو إصابة في الدماغ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تكن متأكدًا من سريان أي من الحالات أعلاه عليك، استشر طبيبك، أو الممرضة قبل أخذ مُرَّكز الجلوكوز.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عندما يتم إعطاؤك مُرَّكز الجلوكوز، سيراقب الطبيب:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية الإلكتروليتات، مثل الصوديوم والبوتاسيوم في الدم (إلكتروليتات البلازما).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستوى السكر (الجلوكوز).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نسبة السوائل في جسمك (توازن السوائل).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حموضة الدم والبول (التغيّرات في التوازن الحمضي القاعدي).</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيقوم الطبيب بتعديل مقدار مُرَّكز الجلوكوز الذي يتم إعطاؤه لك، وذلك وفقاً لنتائج هذه الاختبارات. وهي ستظهر للطبيب إذا كنت بحاجة إلى نسبة إضافية من البوتاسيوم، أحد الإلكتروليتات (الأملاح) في الدم. يُمكن إعطاؤها في الوريد إذا لزم الأمر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا لاحتواء مُرَّكز الجلوكوز على السكر (الجلوكوز)، فإنه يمكن أن يسبب فرط سكر الدم (ارتفاع السكر في الدم). في حالة حدوث ذلك، فقد يقوم طبيبك بما يلي:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعديل سرعة التسريب.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إعطائك الأنسولين لتقليل مستوى السكر في دمك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إعطاء كمية إضافية من البوتاسيوم إذا لزم الأمر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">وهذا أمر مهمّ بشكل خاصّ:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مريض السكري.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت الكليتان لا تعملان بشكل طبيعي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرّضت مؤخراً لسكتة دماغية (سكتة دماغية إقفارية حادّة). يمكن لمستويات السكر العالية في الدم أن تزيد من سوء آثار السكتة الدماغية وتؤثّر سلباً على التعافي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني اضطرابات في الأيض بسبب الجوع الشديد أو اتّباع نظام غذائي لا تتوفّر فيه نسبة مناسبة من المواد الغذائية اللازمة (نقص التغذية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان مستوى الثيامين منخفضاً (فيتامين B1). يمكن أن يحدث ذلك إذا كنت تعاني من اعتماد مزمن على الكحول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">يجب إعطاء الأطفال مُرَّكز الجلوكوز بحذر تامّ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب أن يُعطي مُرَّكز الجلوكوز للأطفال على يد طبيب أو ممرّضة. يجب أن يحدّد طبيب متخصّص في رعاية الأطفال الكمية التي يجب إعطاؤها لهم، ويعتمد ذلك على عمر الطفل ووزنه وحالته. وإذا تمّ استخدام مُرَّكز الجلوكوز من أجل إعطاء أو تخفيف تركيز دواء آخر، أو إذا أُعطيَت أدوية أخرى في الوقت عينه، قد يؤثّر ذلك في الجرعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عندما يُعطى مُرَّكز الجلوكوز للأطفال، يقوم طبيب الطفل بأخذ عيّنات للدم والبول بهدف مراقبة كميّة الإلكتروليتات مثل البوتاسيوم في الدم (إلكتروليتات البلازما).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُعدّ الأطفال حديثي الولادةً وتحديداً الخدّج أو ذوو الوزن الخفيف جداً أكثر عرضة لانخفاض أو ارتفاع السكر في الدم، وبالتالي فهم بحاجة إلى مراقبة دقيقة أثناء العلاج بواسطة المحاليل الوريدية التي تحتوي على الجلوكوز لضمان التحكّم بشكل ملائم بمستويات السكر من أجل تجنّب تأثيرات سلبية طويلة الأمد. يمكن أن يتسبب انخفاض مستويات السكر عند الأطفال حديثي الولادة في حدوث نوبات مطولة وغيبوبة وتلف الدماغ. وقد ارتبطت مستويات السكر العالية بالنزيف في الدماغ، والعدوى البكتيرية والفطرية، وأضرار بالعين (اعتلال الشبكية الذي يصيب الخداج)، والالتهابات في الأمعاء، ومشاكل الرئة (خَلَلُ التَّنَسُّجِ القَصَبِيُّ الرِّئَوِيّ)، وطول فترة الإقامة في المستشفى والوفاة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عند إعطاء الجلوكوز لطفل حديث الولادة، يمكن وصل كيس المحلول بجهاز مضخّة تسريب، ما يخوّل إعطاء كمية المحلول المطلوبة بشكل دقيق عبر الفاصل الزمني المحدّد. سيقوم الطبيب أو ممرّضتك بمراقبة الجهاز لضمان إعطاء الجلوكوز بشكل آمن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُعدّ الأطفال (بما في ذلك الأطفال حديثي الولادة والأطفال الأكبر سناً) الذين يُعطَون مُرَّكز الجلوكوز أكثر عرضة لنقص الصوديوم في الدم واضطراب يؤثّر في الدماغ بسبب انخفاض مستويات الصوديوم (اعتلال دماغي ناجم عن نقص صوديوم الدم).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول أدوية أخرى مع مُرَّكز الجلوكوز </strong></p><p dir="RTL">أخبر طبيبك أو الممرض إذا كنت تتناول أدوية أخرى أو تناولت أي أدوية أخرى مؤخرًا أو قد تتناول أدوية أخرى. قد تتأثّر الأدوية الأخرى ومُرَّكز الجلوكوز معاً إذا تمّ تناولها في الوقت عينه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تعمل بعض الأدوية مثل هرمون الفازوبريسين. وهذه قد تشمل:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المضادة للسكري (كلوربروباميد)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دواء الكوليسترول (كلوفيبرات)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض أدوية السرطان (فينكريستي، إيفوسفاميد، سيكلوفوسفاميد)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات امتصاص السيروتونين الانتقائية (تُستخدَم لعلاج الاكتئاب)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫الأدوية المضادة للذهان أو المسكنات الأفيونية لتخفيف الألم الشديد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية للألم و/أو الالتهاب (المعروفة أيضًا باسم مضادات الالتهاب غير الستيرويدية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تحاكي أو تقوي تأثيرات فازوبريسين، مثل ديسموبريسين (يُستخدَم لعلاج زيادة العطش والتبول)، وتيرليبريسين (يُستخدَم لعلاج نزيف المريء)، وأوكسيتوسين (يُستخدَم للحث على المخاض)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المضادة للصرع (كاربامازيبين وأوكسكاربازيبين)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مدرات البول (أقراص الماء).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نقل الدم أثناء تلقي مُرَّكز الجلوكوز </strong></p><p dir="RTL">أثناء تلقي مُرَّكز الجلوكوز لا يجوز نقل الدم إليك من خلال نفس الأنبوب المستخدم لتلقي مُرَّكز الجلوكوز. لا يجوز كذلك نقل الدم قبل أو بعد استخدام نفس أنبوب التسريب، حيث قد يؤدي ذلك إلى حدوث جلطة دموية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة والخصوبة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنتِ حاملاً أو ترضعين رضاعة طبيعية أو تعتقدين أنكِ حامل أو تخططين للإنجاب، يجب استشارة الطبيب أو الممرضة قبل تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>الحمل</em></strong></p><p dir="RTL">يمكن استخدام مُرَّكز الجلوكوز أثناء الحمل. ولكن ينبغي توخّي الحذر عند استخدام مُرَّكز الجلوكوز أثناء الولادة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>الخصوبة </em></strong></p><p dir="RTL">لا توجد بيانات كافية عن تأثير الجلوكوز في الخصوبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>الرضاعة الطبيعية </em></strong></p><p dir="RTL">لا توجد بيانات كافية عن تأثير تلقي مُرَّكز الجلوكوز أثناء الرضاعة الطبيعية. يمكن تلقّي مُرَّكز الجلوكوز أثناء الرضاعة الطبيعية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستعمال الأجهزة والمعدات</strong></p><p dir="RTL">لا توجد معلومات عن آثار الجلوكوز على القدرة على تشغيل مركبة أو غيرها من الآلات الثقيلة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يعطيك الطبيب أو المُمرّضة مُرَّكز الجلوكوز.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة المعتادة</strong></p><p dir="RTL">وسيقرّر الطبيب النسبة التي تحتاج إليها والتوقيت المناسب. سوف تعتمد الجرعة على:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عمرك ووزنك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سبب استخدام الدواء</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>طريقة تحضير وإعطاء مُرَّكز الجلوكوز</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يتم تخفيف مُرَّكز الجلوكوز بمحاليل تغذية أخرى قبل أن يتم إعطاؤه لك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يتم التخفيف مع التعقيم بواسطة شخص مدرب ومؤهل.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يتم تخزين المحلول المخفف في درجة حرارة 2 إلى 8 مئوية ويتم استخدامه خلال 24 ساعة من الخلط.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم إعطاؤه لك عبر أنبوب بلاستيكي، حيث يوضع بحرص شديد بداخل وريد في الصدر عادةً.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سوف يتحقق طبيبك من توافق أية أدوية تتم إضافتها إلى التسريب مع مُرَّكز الجلوكوز.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قبل وأثناء التسريب، سيراقب طبيبك:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية السوائل في جسمك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حموضة الدم والبول</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية الإلكتروليتات في جسمك (خاصة الصوديوم، في المرضى الذين لديهم مستويات عالية من هرمون فازوبريسين، أو الذين يتناولون أدوية أخرى تزيد من تأثير فازوبريسين).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال تمّ حقن نسبة من مُرَّكز الجلوكوز أعلى من المعدّل الطبيعي</strong></p><p dir="RTL">في حال تمّ حقن نسبة من مُرَّكز الجلوكوز فائضة عن المعدّل الطبيعي (الإفراط في التسريب)، أو تمّ حقن المحلول بسرعة أو مرات متعددة، قد تظهر الأعراض التالية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم السوائل في الأنسجة، ما قد يتسبّب بتورّم (وَذَمَة) أو التسمّم المائي مع انخفاض مستوى الصوديوم في الدم إلى مستوى أقل من المعدل الطبيعي (نقص الصوديوم في الدم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستوى السكر في الدم عن المعدل الطبيعي (ارتفاع السكر في الدم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يصبح الدم شديد التركيز (فرط الأسمولية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود سكر في البول (ارتفاع السكر في البول)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في كمية البول التي تنتجها (إدرار البول التناضحي)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقد الجسم للماء بشكل مفرط (التجفاف)</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا ظهرت لديك أي من هذه الأعراض، يجب عليك إبلاغ طبيبك على الفور. سيتم إيقاف التسريب أو تخفيفه. ثم يعطيك الطبيب الأنسولين وسيتم علاجك حسب الأعراض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يتسبب هذا الدواء في حدوث آثار جانبية، على الرغم من أن هذه الآثار لا تحدث لجميع الأشخاص.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تشمل الآثار الجانبية المحتملة:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رد فعل فرط التحسس، بما في ذلك رد فعل تحسسي خطير يسمى تأق (ظواهر محتملة لدى المرضى الذين يعانون من حساسية من الذرة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيّرات في مستويات الإلكتروليتات (اختلال توازن الإلكتروليتات) الموجودة في الدم، بما فيها:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات منخفضة من الصوديوم في الدم يمكن الحصول عليها أثناء الإقامة في المستشفى (نقص الصوديوم في الدم الناتج عن عدوى المستشفيات) والاضطراب العصبي ذي الصلة (اعتلال دماغي ناجم عن نقص صوديوم الدم). يمكن أن يؤدي نقص الصوديوم في الدم إلى إصابة في الدماغ لا يمكن الشفاء مها وإلى الوفاة بسبب (أوديما دماغية أو التَوَرُّم) (راجع أيضًا في القسم &quot;تحذيرات واحتياطات&quot;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستوى السكر في الدم (ارتفاع السكر في الدم).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة السوائل في الأوعية الدموية (تخفيف الدم وزيادة كمية الدم في الدورة الدموية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود سكر في البول (بيلة سكرية).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود الفعل المتعلقة بطريقة الحقن:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى، تفاعل حُمَّوِيّ.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى في موضع الحقن.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسرب مُرَّكز الجلوكوز في الأنسجة حول الوريد (انصباب دمي). يمكن أن يؤدي ذلك إلى تلف الأنسجة ويسبب التندب.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تكوين جلطة دموية (تخثر وريدي) في موضع التسريب، ما يسبب الألم أو التَوَرُّم والاِحمِرَار في منطقة الجلطة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تهيج والتهاب الوريد الذي يتم فيه ضخ المحلول (التهاب وريدي). يمكن أن يسبب هذا اِحمِرَارًا أو ألمًا أو حرقًا وتَوَرُّمًا على طول مسار الوريد الذي يتم فيه تسريب المحلول.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم موضعي أو رد فعل (اِحمِرَار أو تَوَرُّم في موضع التسريب).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاِرتِجَاف.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التَعَرُّق.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشكل جسيمات صغيرة تسد الأوعية الدموية في الرئتين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالة حدوث أي آثار جانبية، يجب إيقاف التسريب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن التداخلات غير المرغوبة المشتبه بها</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب استشارة الطبيب أو الممرضة أو الصيدلي إذا تعرّضت لأيٍّ من الآثار الجانبية. يتضمن ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً (انظر التفاصيل أدناه). بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في تقديم المزيد من المعلومات عن سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهيئة العامة للغذاء والدواء: 19999</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُرجى الاتصال بالهيئة المختصة ذات الصلة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ الدواء بعيدًا عن مرأى الأطفال ومتناول أيديهم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يقوم طاقم المستشفى بالتأكد من تخزين المنتج والتخلص منه بشكل صحيح وعدم استخدامه بعد انتهاء تاريخ الصلاحية المدون على المنتج. يُرجى الاطلاع على ظروف التخزين المذكورة أدناه، إذا كنت بحاجة إلى معرفتها.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يُحفظ هذا الدواء في درجة حرارة تزيد عن 25 درجة مئوية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتفظ بالدواء في عبوته الأصلية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستعمل مُرَّكز الجلوكوز بعد تاريخ انتهاء الصلاحية المطبوع على المُلصق. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم استخدام مُرَّكز الجلوكوز إذا لم يكن المحلول رائقًا أو إذا كان الكيس تالفًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُستخدم كل كيس مرة واحدة. ويجب التخلص من أي مركز متبقي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">هذه النشرة لا تتضمن كل المعلومات الخاصة بهذا الدواء. إذا كانت لديك أية استفسارات أو كنت غير متأكد من شيء ما، فاسأل اختصاصي الرعاية الصحية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>على ماذا يحتوي مُرَّكز الجلوكوز</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادّة الفعالة هي الجلوكوز مونوهيدرات 77% w/v (770 جرام لكل 1000 مل) وهذا يعادل الجلوكوز اللامائي 70% w/v (700 جرام لكل 1000 مل).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكون الآخر هو الماء المعقم (يطلق عليه &quot;ماء للحقن&quot;).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو مُرَّكز الجلوكوز وما محتويات العبوة</strong></p><p dir="RTL">مُرَّكز الجلوكوز هو محلول رائق مصفر قليلاً. يتوفر في أكياس بلاستيكية مرنة، تحتوي على 2000 مل من المُركز.</p><p dir="RTL">يتم توفير الأكياس في عبوات كرتون. تحتوي كل عبوة كرتونية على <strong>6</strong> أكياس سعة 2000 مل</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>صاحب ترخيص التسويق</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>Baxter Healthcare Corporation</strong></p><p dir="RTL">60015 Deerfield, IL</p><p dir="RTL">USA</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>جهة التصنيع</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>Baxter Healthcare Corporation</strong></p><p dir="RTL">65 Pitts Station Rd</p><p dir="RTL">28752 Marion, NC</p><p dir="RTL">USA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت آخر مراجعة لهذه النشرة في أكتوبر 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dextrose 70% w/v Concentrate for solution for infusion.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Anhydrous Glucose 70 %w/v equivalent to 		700 g per 1000 ml 
Or
Glucose Monohydrate 				770 g per 1000 ml 

For the full list of excipients, see Section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concentrate for solution for infusion.

Clear, slightly yellow solution. 

Glucose 70% w/v has an osmolarity of 3885 mOsmol/L.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glucose 70% w/v is for use in admixtures to provide temporary relief from the symptoms of increased intracranial pressure and hypoglycaemic coma and is also indicated for the supplementation of energy in parenteral nutrition.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>&nbsp;</p><p>The dosage and rate of administration of Glucose 70% w/v are determined by several factors including the indication for use and the patient&rsquo;s age, weight and clinical condition.</p><p>&nbsp;</p><p>Fluid balance, serum glucose, serum sodium and other electrolytes should be monitored before and during administration, especially in patients with increased non-osmotic vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs due to the risk of hyponatraemia.</p><p>&nbsp;</p><p>Monitoring of serum sodium is particularly important for physiologically hypotonic fluids. Glucose 70% w/v may become extremely hypotonic after administration due to glucose metabolisation in the body (see sections 4.4, 4.5 and 4.8).</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Glucose 70% w/v is for administration by intravenous infusion following appropriate dilution or incorporation in to a parenteral nutrition admixture.</p><p>&nbsp;</p><p>Administration of hyperosmolar solutions may cause venous irritation and phlebitis.</p><p>&nbsp;</p><p>The resultant admixture should be administered through a central or peripheral venous line depending on its final osmolarity. If the final mixture, to be administered, is hypertonic it may cause irritation of the vein when administered into a peripheral vein.</p><p>&nbsp;</p><p>The infusion rate and volume depends on the age, weight, clinical and metabolic conditions of the patient, as well as concomitant therapy.</p><p>&nbsp;</p><p>A gradual increase of flow rate should be considered when starting administration of glucose-containing products.</p><p>&nbsp;</p><p>To reduce the risk of hypoglycaemia after discontinuation, a gradual decrease in flow rate before stopping the infusion should be considered.</p><p>&nbsp;</p><p>Electrolyte supplementation may be indicated according to the clinical needs of the patient.</p><p>&nbsp;</p><p>As indicated on an individual basis, vitamins and trace elements and other components (including amino acids and lipids) can be added to the parenteral regimen to meet nutrient needs and prevent deficiencies and complications from developing.</p><p>&nbsp;</p><p>Dilute Glucose 70% w/v before use to a concentration which will, when administered with an amino acid (nitrogen) source, result in an appropriate calorie to gram of nitrogen ratio and which has an osmolarity consistent with the route of administration.</p><p>&nbsp;</p><p>When Glucose 70% w/v is used in conjunction with amino acids, the rate of administration of glucose should not exceed 1g/kg/hour for optimal protein anabolism.</p><p>&nbsp;</p><p><u>Use in Paediatric Patients </u></p><p>The infusion rate and volume depends on the age, weight, clinical and metabolic conditions of the patient, concomitant therapy and should be determined by the consulting physician experienced in paediatric intravenous fluid therapy (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Contra-indicated in patients with:
•	Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. See sections 4.4 and 4.8 for corn allergies 
•	Clinically significant hyperglycaemia

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>WARNINGS</p><p>Not for direct intravenous infusion. Must be appropriately diluted before use. The admixture obtained should be administered through a central or peripheral venous line depending on its final osmolarity.</p><p>&nbsp;</p><p>Unless appropriately diluted infusion of hypertonic glucose solutions into a peripheral vein may result in vein irritation, vein damage, and thrombosis. Strongly hypertonic solutions should only be administered through an indwelling intravenous catheter with the tip located in a large vein such as the superior vena cava.</p><p>&nbsp;</p><p>Prolonged intravenous infusion of this solution may cause thrombophlebitis extending from the site of infusion.</p><p>&nbsp;</p><p><u>Dilution and other effects on serum electrolytes</u></p><p>Glucose intravenous infusions are usually isotonic solutions. In the body, however, glucose containing fluids can become extremely physiologically hypotonic due to rapid glucose metabolisation (see section 4.2).</p><p>&nbsp;</p><p>Depending on the tonicity of the solution, the volume and rate of infusion and depending on a patient&rsquo;s underlying clinical condition and capability to metabolize glucose, intravenous administration of glucose can cause:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperosmolality, osmotic diuresis and dehydration</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypoosmolality</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Electrolyte disturbances such as:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypo- or hyperosmotic hyponatraemia (see below),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypokalaemia,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypophosphatemia,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypomagnesaemia,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; overhydration/hypervolemia and, for example, congested states, including pulmonary congestion and oedema.</p><p>&nbsp;</p><p>The above effects do not only result from the administration of electrolyte-free fluid but also from glucose administration.</p><p>&nbsp;</p><p><u>Hyponatraemia</u></p><p>Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, postoperative stress, infections, burns, and CNS diseases), patients with heart-, liver- and kidney diseases and patients exposed to vasopressin agonists (see section 4.5) are at particular risk of acute hyponatraemia upon infusion of hypotonic fluids.</p><p>&nbsp;</p><p>Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (brain oedema) characterized by headache, nausea, seizures, lethargy and vomiting. Patients with brain oedema are at particular risk of severe, irreversible and life-threatening brain injury.</p><p>Children, women in the fertile age and patients with reduced cerebral compliance (e.g. meningitis, intracranial bleeding, and cerebral contusion) are at particular risk of the severe and life-threatening brain swelling caused by acute hyponatraemia.</p><p>&nbsp;</p><p>Hypoosmotic hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, cerebral oedema, and death. Acute symptomatic hyponatraemic encephalopathy is considered a medical emergency.</p><p>&nbsp;</p><p>The risk for developing hypoosmotic hyponatraemia is increased, for example,</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in children</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in elderly patients</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in women</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; postoperatively</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in persons with psychogenic polydipsia</p><p>&nbsp;</p><p>Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.</p><p>&nbsp;</p><p>Particular caution is advised in patients at increased risk of water and electrolyte disturbances that could be aggravated by increased free water load, hyperglycaemia or possibly required insulin administration (see below).</p><p>&nbsp;</p><p><u>Hyperglycaemia</u></p><p>As with the intravenous administration of nutrients (e.g., glucose, amino acids and lipids) in general, metabolic complications may occur if the nutrient intake is not adapted to the patient&rsquo;s requirements, or the metabolic capacity of any given dietary component is not accurately assessed. Adverse metabolic effects may arise from administration of inadequate or excessive nutrients or from inappropriate composition of an admixture for a particular patient&rsquo;s needs.</p><p>&nbsp;</p><p>Rapid administration of glucose solutions may produce substantial hyperglycaemia and a hyperosmolar syndrome.</p><p>&nbsp;</p><p>To reduce the risk of hyperglycaemia-associated complications, the infusion rate must be adjusted and/or insulin administered.</p><p>&nbsp;</p><p>Intravenous glucose should be administered with caution in patients with, for example:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; impaired glucose tolerance (such as in patients with renal failure or diabetes mellitus, or in the presence of sepsis, trauma, or shock),</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe malnutrition (risk of precipitating a refeeding syndrome),</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thiamine deficiency, e.g., in patients with chronic alcoholism (risk of severe lactic acidosis due to impaired oxidative metabolisation of pyruvate),</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; water and electrolyte disturbances that could be aggravated by increased glucose and/or free water load (see above).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients with ischemic stroke or severe traumatic brain injury</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; avoid infusion within the first 24 hours following head trauma. Monitor blood glucose closely as early hyperglycaemia has been associated with poor outcomes in patients with severe traumatic brain injury.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; newborns (see below).</p><p>&nbsp;</p><p><u>Effects on Insulin Secretion</u></p><p>Prolonged intravenous administration of glucose and associated hyperglycaemia may result in decreased rates of glucose-stimulated insulin secretion.</p><p>&nbsp;</p><p><u>Hypersensitivity Reactions</u></p><p>Hypersensitivity/infusion reactions, including anaphylactic/anaphylactoid reactions, have been reported (see section 4.8).</p><p>&nbsp;</p><p>Solutions containing glucose should be used with caution, if at all, in patients with known allergy to corn or corn products.</p><p>&nbsp;</p><p>The infusion must be stopped immediately if any signs or symptoms of a suspected hypersensitivity reaction develop. Appropriate therapeutic countermeasures must be instituted as clinically indicated.</p><p>&nbsp;</p><p><u>Refeeding syndrome</u></p><p>Refeeding severely undernourished patients may result in the refeeding syndrome that is characterized by the shift of potassium, phosphorus, and magnesium intracellularly as the patient becomes anabolic. Thiamine deficiency and fluid retention may also develop. Careful monitoring and slowly increasing nutrient intakes while avoiding overfeeding can prevent these complications.</p><p>&nbsp;</p><p><u>Liver disorders</u></p><p>Hepatobiliary disorders including cholestasis, hepatic steatosis, fibrosis and cirrhosis, possibly leading to hepatic failure, as well as cholecystitis and cholelithiasis are known to develop in some patients on parenteral nutrition.</p><p>&nbsp;</p><p>The etiology of these disorders is thought to be multifactorial and may differ between patients. Patients developing abnormal laboratory parameters or other signs of hepatobiliary disorders should be assessed early by a clinician knowledgeable in liver diseases in order to identify possible causative and contributory factors, and possible therapeutic and prophylactic interventions.</p><p>&nbsp;</p><p><u>Catheter infection and sepsis</u></p><p>Infection and sepsis may occur as a result of the use of intravenous catheters to administer parenteral formulations, poor maintenance of catheters or contaminated solutions.</p><p>&nbsp;</p><p>Immunosuppression and other factors such as hyperglycaemia, malnutrition and/or their underlying disease state may predispose patients to infectious complications.</p><p>&nbsp;</p><p>Careful symptomatic and laboratory monitoring for fever/chills, leukocytosis, technical complications with the access device, and hyperglycaemia can help recognize early infections.</p><p>&nbsp;</p><p>The occurrence of septic complications can be decreased with heightened emphasis on aseptic technique in catheter placement, maintenance, as well as aseptic technique in nutritional formula preparation.</p><p>&nbsp;</p><p><u>Precipitates</u></p><p>Pulmonary vascular precipitates have been reported in patients receiving parenteral nutrition. In some cases, fatal outcomes have occurred. Excessive addition of calcium and phosphate increases the risk of the formation of calcium phosphate precipitates. Precipitates have been reported even in the absence of phosphate salt in the solution.</p><p>&nbsp;</p><p>In addition to inspection of the solution, the infusion set and catheter should also periodically be checked for precipitates.</p><p>&nbsp;</p><p>If signs of pulmonary distress occur, the infusion should be stopped and medical evaluation initiated.</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>The infusion rate and volume depends on the age, weight, clinical and metabolic conditions of the patient, concomitant therapy, and should be determined by a consulting physician experienced in paediatric intravenous fluid therapy.</p><p>&nbsp;</p><p>In order to avoid potentially fatal over infusion of intravenous fluids to the neonate, special attention needs to be paid to the method of administration.</p><p>&nbsp;</p><p>When using a syringe pump to administer intravenous fluids or medicines to neonates, a bag of fluid should not be left connected to the syringe.</p><p>&nbsp;</p><p>When using an infusion pump all clamps on the intravenous administration set must be closed before removing the administration set from the pump, or switching the pump off. This is required regardless of whether the administration set has an anti-free flow device.</p><p>&nbsp;</p><p>The intravenous infusion device and administration equipment must be frequently monitored.</p><p>&nbsp;</p><p><em><u>Paediatric glycaemia related issues</u></em></p><p>Newborns, especially those born premature and with low birth weight - are at increased risk of developing hypo- or hyperglycaemia and therefore need close monitoring during treatment with intravenous glucose solutions to ensure adequate glycaemic control in order to avoid potential long term adverse effects.</p><p>&nbsp;</p><p>Hypoglycaemia in the newborn can cause prolonged seizures, coma and brain damage. Hyperglycaemia has been associated with intraventricular haemorrhage, late onset bacterial and fungal infection, retinopathy of prematurity, necrotizing enterocolitits, bronchopulmonary dysplasia, prolonged length of hospital stay, and death.</p><p>&nbsp;</p><p><em><u>Paediatric hyponatraemia-related issues</u></em></p><p>Children (including neonates and older children) are at increased risk of developing hypoosmotic hyponatraemia as well as for developing hyponatraemic encephalopathy.</p><p>&nbsp;</p><p>Plasma electrolyte concentrations should be closely monitored in the paediatric population.</p><p>&nbsp;</p><p>Rapid correction of hypoosmotic hyponatraemia is potentially dangerous (risk of serious neurologic complications). Dosage, rate, and duration of administration should be determined by a physician experienced in paediatric intravenous fluid therapy.</p><p>&nbsp;</p><p><u>Geriatric Use </u></p><p>When selecting the type of infusion solution and the volume/rate of infusion for a geriatric patient, consider that geriatric patients are generally more likely to have cardiac, renal, hepatic impairment, and other diseases or concomitant drug therapy.</p><p>&nbsp;</p><p><u>Blood </u></p><p>Glucose solution (an aqueous, i.e., electrolyte-free glucose solution) should not be administered through the same equipment as whole blood, as haemolysis and pseudoagglutination can occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Both the glycaemic effects of intravenous glucose and its effects on water and electrolyte balance should be taken into account when using intravenous glucose in patients treated with other substances that affect glycaemic control, or fluid and/or electrolyte balance.</p><p>&nbsp;</p><p><em><u>Drugs leading to an increased vasopressin effect </u></em></p><p>The below listed drugs increase the vasopressin effect, leading to reduced renal electrolyte free water excretion and increase the risk of hospital acquired hyponatraemia following inappropriately balanced treatment with i.v. fluids (see sections 4.2, 4.4 and 4.8).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drugs stimulating vasopressin release, e.g.: Chlorpropamide, clofibrate, carbamazepine, vincristine, selective serotonin reuptake inhibitors, 3.4- methylenedioxy-N-methamphetamine, ifosfamide, antipsychotics, narcotics</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drugs potentiating vasopressin action, e.g.: Chlorpropamide, NSAIDs, cyclophosphamide</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vasopressin analogues, e.g.: Desmopressin, oxytocin, terlipressin</p><p>&nbsp;</p><p>Other medicinal products increasing the risk of hyponatraemia also include diuretics in general and antiepileptics such as oxcarbazepine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Intrapartum maternal intravenous glucose infusion may result in foetal insulin production, with an associated risk of foetal hyperglycaemia and metabolic acidosis as well as rebound hypoglycaemia in the neonate.</p><p>&nbsp;</p><p><em>Pregnancy</em></p><p>Glucose solution can be used during pregnancy. However, caution should be exercised when glucose solution is used intrapartum.</p><p>&nbsp;</p><p>Glucose 70% w/v should be administrated with special caution for pregnant women during labour particularly if administered in combination with oxytocin due to the risk of hyponatraemia (see section 4.4, 4.5 and 4.8).</p><p>&nbsp;</p><p><em>Fertility</em></p><p>There are no adequate data of the effect of Glucose on fertility.</p><p>&nbsp;</p><p><em>Lactation</em></p><p>Lactation There are no adequate data of using Glucose solution during lactation. Glucose solutions have been used during lactation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information on the effects of intravenous glucose on the ability to operate a vehicle or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions have been reported in the post-marketing experience, listed by MedDRA System Organ Class (SOC), then, where feasible, by Preferred Term in order of severity.</p><table border="1" cellspacing="0" cellpadding="0"><thead><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Drug Reaction</strong></p><p><strong>(MedDRA term)</strong></p></td><td style="vertical-align:top"><p><strong>Frequency*</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p>Anaphylactic reaction**</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity**</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Metabolism and nutrition disorders</strong></p></td><td style="vertical-align:top"><p>Hyperglycaemia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hospital Acquired Hyponatraemia***</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="vertical-align:top"><p>Rash</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>Hyponatraemic encephalopathy***</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top"><p>Chills</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Infection at site of injection</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Thrombophlebitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Infusion site reactions including,</p><p>&bull; Infusion site phlebitis</p><p>&bull; Infusion site erythema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr></thead></table><p><sup>* &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cannot be estimated from the available data </sup></p><p><sup>** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Potential manifestation in patients with allergy to corn, see section 4.4. </sup></p><p><sup>*** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hospital acquired hyponatraemia may cause irreversible brain injury and death due to development of acute hyponatraemic encephalopathy (see sections 4.2 and 4.4).</sup></p><p>&nbsp;</p><p>Other adverse reactions reported with glucose injection/infusions include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infusion site thrombophlebitis (associated with hyperosmolar solutions)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Adverse reactions reported when glucose is used with parenteral nutrition:</p><p>Hepatic failure, Hepatic cirrhosis, Hepatic fibrosis, Cholestasis, Hepatic steatosis, Blood bilirubin increased, Hepatic enzyme increased, Cholecystitis, Cholelithiasis</p><p>Pulmonary vascular precipitates</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of medicinal product is important. It allows continued monitoring of the benefit/risk balance of medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system as per following contact details:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia:</p><table border="1" cellspacing="0" cellpadding="0" style="width:567px"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other GCC States:</p><table border="1" cellspacing="0" cellpadding="0" style="width:567px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prolonged administration or rapid infusion of large volumes of the product may cause hyperosmolarity and hyponatraemia, dehydration, hyperglycaemia, hyperglucosuria, osmotic diuresis (due to hyperglycaemia) and water intoxication and oedema. Severe hyperglycaemia and hyponatraemia may be fatal (see sections 4.4 and 4.8).</p><p>In case of suspected overdose, treatment must be stopped immediately. Management of overdose is symptomatic and supportive, with appropriate monitoring.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This solution should not be used in conjunction with additives incompatible with glucose, see section 6.6</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened: 12 months 
It is recommended that the product is used immediately after removal from the overpouch. From a microbiological point of view, any admixture should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C. Preparation of the admixture should take place under controlled and validated aseptic conditions.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.</p><p>&nbsp;</p><p>For further information, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The product is a clear, colourless solution in a plastic Viaflex&reg; container. The plastic is a PVC designated PL-146.</p><p>The containers are sealed in a plastic overpouch.</p><p>The solutions are supplied in 6 bags of 2000 mL fill volumes in .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dilution or addition to parenteral nutrition admixtures must take place in controlled and validated aseptic conditions.</p><p>&nbsp;</p><p>The product should be inspected visually for particulate matter and discoloration after admixing and prior to administration. Do not administer unless the solution is clear and the seal is intact.</p><p>&nbsp;</p><p>Check compatibility with other admixture components before use.</p><p>&nbsp;</p><p>Additives known or determined to be incompatible with glucose as a diluent should not be used. The instructions for use of the medication to be added, including information on storage, must be consulted.</p><p>&nbsp;</p><p>Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of the glucose solution is appropriate.</p><p>&nbsp;</p><p>Mix the solution thoroughly when additives have been introduced.</p><p>&nbsp;</p><p>Use of an in-line filter is recommended during administration of all parenteral solutions where possible.</p><p>&nbsp;</p><p>Single use only.</p><p>&nbsp;</p><p>Do not store partially used bags. Discard any unused portion, waste materials and all associated devices.</p><p>&nbsp;</p><p><u>Risk of Air Embolism</u></p><p>Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container is completed.</p><p>&nbsp;</p><p>Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration.</p><p>&nbsp;</p><p>Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Healthcare Corporation
60015 Deerfield, IL
USA

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2019 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>